BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kravarusic J, Aleppo G. Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes. Endocrinology and Metabolism Clinics of North America 2020;49:37-55. [DOI: 10.1016/j.ecl.2019.10.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Préau Y, Galie S, Schaepelynck P, Armand M, Raccah D. Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study §. Sensors (Basel) 2021;21:6131. [PMID: 34577338 DOI: 10.3390/s21186131] [Reference Citation Analysis]
2 Pedone E, Laurenzi A, Allora A, Bolla AM, Caretto A. Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now? Exploration of Medicine 2020;1:314-30. [DOI: 10.37349/emed.2020.00021] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Prendin F, Del Favero S, Vettoretti M, Sparacino G, Facchinetti A. Forecasting of Glucose Levels and Hypoglycemic Events: Head-to-Head Comparison of Linear and Nonlinear Data-Driven Algorithms Based on Continuous Glucose Monitoring Data Only. Sensors (Basel) 2021;21:1647. [PMID: 33673415 DOI: 10.3390/s21051647] [Reference Citation Analysis]
4 Montero AR, Toro-Tobon D, Gann K, Nassar CM, Youssef GA, Magee MF. Implications of remote monitoring Technology in Optimizing Traditional Self-Monitoring of blood glucose in adults with T2DM in primary care. BMC Endocr Disord 2021;21:222. [PMID: 34758807 DOI: 10.1186/s12902-021-00884-6] [Reference Citation Analysis]
5 Carral San Laureano F, Tomé Fernández-Ladreda M, Jiménez Millán AI, García Calzado C, Ayala Ortega MDC. Insulin doses requirements in patients with type 1 diabetes using glargine U300 or degludec in routine clinical practice. J Investig Med 2021;69:983-8. [PMID: 33771843 DOI: 10.1136/jim-2020-001633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Aleppo G. Clinical Application of Time in Range and Other Metrics. Diabetes Spectr 2021;34:109-18. [PMID: 34149251 DOI: 10.2337/ds20-0093] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lin YK, Fisher SJ, Pop-Busui R. Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies. J Diabetes Investig 2020;11:1388-402. [PMID: 32403204 DOI: 10.1111/jdi.13290] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
8 Carlson AL, Huyett LM, Jantz J, Chang A, Vienneau T, Ly TT. Improved glycemic control in 3,592 adults with type 2 diabetes mellitus initiating a tubeless insulin management system. Diabetes Research and Clinical Practice 2021;174:108735. [DOI: 10.1016/j.diabres.2021.108735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]